The 2020 Dealmakers’ Intentions Study will be released in July. Contact us to be added to our email list to be notified when it’s live.
The Syneos Health Dealmakers’ Intentions Study is a forward-looking measure of dealmaking activity in the pharmaceutical and biotech industries. While there are many quality sources of information that look historically at past deal trends, this survey offers a prospective view of the partnering and licensing landscape for the year ahead. Now in its 12th year, this survey provides a unique perspective on these trends – by surveying business development professionals from pharmaceutical and biotechnology companies of all sizes, we are able to generate forward-looking insights based on dealmakers' general expectations for activity in the coming year.
While the Dealmakers’ Intentions Study has traditionally been presented at the BIO International Convention, due to our current unique environment, the report will now be released in July.
Contact us to be added to our email list to be notified when it’s live.